BRIEF published on 12/18/2025 at 22:10, 11 hours 58 minutes ago Abivax joins the Nasdaq Biotechnology index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 11 hours 58 minutes ago Abivax rejoint l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 11 hours 58 minutes ago Abivax intègre l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Indice Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 11 hours 58 minutes ago Abivax Joins Nasdaq Biotechnology Index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology Index
PRESS RELEASE published on 12/18/2025 at 22:05, 12 hours 3 minutes ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'Indice Biotechnologie du Nasdaq, témoignant de sa croissance et de ses avancées cliniques. Le NBI suit les performances des sociétés du secteur Biotechnologie Abivax Nasdaq Clinique NBI
PRESS RELEASE published on 12/18/2025 at 22:05, 12 hours 3 minutes ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'indice Nasdaq Biotechnology, rejoignant le NBI avec impact le 22 décembre 2025. Un pas significatif pour la société de biotechnologie française Biotechnologie Abivax France Nasdaq Biotechnology Indice
PRESS RELEASE published on 12/18/2025 at 22:05, 12 hours 3 minutes ago Abivax to be Added to Nasdaq Biotechnology Index Abivax to be added to Nasdaq Biotechnology Index, reflecting company's progress in developing therapeutics for chronic inflammatory diseases. Inclusion effective December 22, 2025 Biotechnology Abivax Therapeutics Immune Response Nasdaq Biotechnology Index
BRIEF published on 12/17/2025 at 22:10, 1 day 11 hours ago Abivax : 22 Abstracts sur Obefazimod Présentés à l'ECCO 2026 Abivax Obefazimod Efficacité Fibrose MICI
BRIEF published on 12/17/2025 at 22:10, 1 day 11 hours ago Abivax: 22 Abstracts on Obefazimod Presented at ECCO 2026 Abivax Obefazimod Efficiency Fibrosis IBD
BRIEF published on 12/17/2025 at 22:10, 1 day 11 hours ago Abivax dévoile de nouvelles données sur l'obefazimod à l'ECCO 2026 Abivax Obefazimod Rectocolite Hémorragique ECCO 2026 Antifibrotique
Published on 12/19/2025 at 03:15, 6 hours 53 minutes ago Tactical Resources Announces Receipt Of Final Order Approving Arrangement With Plum Acquisition Corp. III
Published on 12/19/2025 at 01:10, 8 hours 58 minutes ago Ostrom Climate Exits Existing UPRIIS ERPA Arrangements
Published on 12/19/2025 at 01:00, 9 hours 8 minutes ago Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited
Published on 12/19/2025 at 00:50, 9 hours 18 minutes ago High Resolution Gravity Survey Targets Challenger Repeats
Published on 12/19/2025 at 00:00, 10 hours 8 minutes ago LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Published on 12/19/2025 at 09:35, 33 minutes ago Top sports physio says football bosses failing to properly protect players' health this Christmas as injuries expected to rise
Published on 12/19/2025 at 09:31, 37 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 12/19/2025 at 09:26, 42 minutes ago Original-Research: SYNBIOTIC SE (von NuWays AG): BUY
Published on 12/19/2025 at 08:30, 1 hour 38 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 hour 38 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 3 hours 8 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 3 hours 8 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 15 hours 38 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
